Ashley James
Psychiatric/Mental Health · Brownsville, KYNPI 1093290512
Payments from drug & device makers
Across 146 payments — averaging $17.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Axsome Therapeutics, Inc.$606
- AbbVie$570
- Lilly USA, LLC$219
- Corcept Therapeutics$198
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$165
- Vanda Pharmaceuticals Inc.$139
- plus $613 from 14 others
What the payments were for
- Food & beverage$2,510100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Axsome Therapeutics, Inc. | 34 | $606 |
| AbbVie | 32 | $570 |
| Lilly USA, LLC | 14 | $219 |
| Corcept Therapeutics | 13 | $198 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 11 | $165 |
| Vanda Pharmaceuticals Inc. | 6 | $139 |
| Bayer | 6 | $105 |
| Alkermes, Inc. | 4 | $79 |
| Novo Nordisk | 4 | $78 |
| Amgen | 4 | $66 |
| Otsuka America Pharmaceutical, Inc. | 3 | $50 |
| Idorsia Pharmaceuticals US Inc | 3 | $47 |
| Supernus Pharmaceuticals, Inc. | 3 | $47 |
| Ironshore Pharmaceuticals Inc. | 2 | $32 |
| Lundbeck LLC | 2 | $31 |
| AstraZeneca | 1 | $22 |
| Astellas Pharma US Inc | 1 | $16 |
| Exact Sciences | 1 | $14 |
| Collegium Pharmaceutical, Inc. | 1 | $13 |
| Corium, LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,510 in reported general payments places this provider in the 75th percentile of 946 psychiatric/mental health providers in Kentucky.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clonazepam | 23 | $866 |
| Vilazodone Hcl | 12 | $564 |
| Duloxetine Hcl | 57 | $462 |
| Ziprasidone Hcl | 11 | $419 |
| Fluvoxamine Maleate | 11 | $387 |
| Hydroxyzine Hcl | 23 | $316 |
| Trazodone Hcl | 50 | $287 |
| Mirtazapine | 25 | $234 |
| Quetiapine Fumarate | 36 | $146 |
| Prazosin Hcl | 17 | $119 |
| Buspirone Hcl | 21 | $116 |
| Aripiprazole | 21 | $110 |
| Clonidine Hcl | 36 | $44 |
| Fluoxetine Hcl | 12 | $36 |
| Escitalopram Oxalate | 13 | $26 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in Brownsville
- Theresa WattsAshland$645K
- Rachel ColeHopkinsville$503K
- Denise de AngelisLouisville$384K
- Jennifer SampangCrestview Hills$322K
- Jeremy FisherSouth Shore$197K
- Jessica EstesLewisport$175K
- Christopher MulloneyNancy$95K
- Davika MattoxMorehead$79K
- Molly LutzCrestview Hills$71K
- Hope SmithHopkinsville$68K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.